Skip to main content
Top
Published in: Archives of Virology 9/2013

01-09-2013 | Original Article

The role of oligomerization for the biological functions of the arenavirus nucleoprotein

Authors: Frank Lennartz, Thomas Hoenen, Maria Lehmann, Allison Groseth, Wolfgang Garten

Published in: Archives of Virology | Issue 9/2013

Login to get access

Abstract

The Lassa virus nucleoprotein (NP) is a multifunctional protein that plays an essential role in many aspects of the viral life cycle, including RNA encapsidation, viral transcription and replication, recruitment of ribonucleoprotein complexes to viral budding sites, and inhibition of the host cell interferon response. While it is known that NP is capable of forming oligomers, both the oligomeric state of NP in mammalian cells and the significance of NP oligomerization for its various functions remain unclear. Here, we demonstrate that Lassa virus NP solely forms trimers upon expression in mammalian cells. Using a minigenome assay we show that mutants that are not able to form stable trimers are no longer functional during transcription and/or replication of the minigenome, indicating that NP trimerization is essential for transcription and/or replication of the viral genome. However, mutations leading to destabilization of the NP trimer did not impact the incorporation of NP into virus-like particles or its ability to suppress interferon-induced gene expression, two important functions of arenavirus NP.
Literature
1.
go back to reference Agnihothram S, Dancho B, Grant K, Grimes M, Lyles D, Nunberg J (2009) Assembly of arenavirus envelope glycoprotein GPC in detergent-soluble membrane microdomains. J Virol 83:9890–10790PubMedCrossRef Agnihothram S, Dancho B, Grant K, Grimes M, Lyles D, Nunberg J (2009) Assembly of arenavirus envelope glycoprotein GPC in detergent-soluble membrane microdomains. J Virol 83:9890–10790PubMedCrossRef
2.
go back to reference Basler CF, Wang X, Mühlberger E, Volchkov V, Paragas J, Klenk HD, Garcia-Sastre A, Palese P (2000) The Ebola virus VP35 protein functions as a type I IFN antagonist. Proc Natl Acad Sci USA 97:12289–12294PubMedCrossRef Basler CF, Wang X, Mühlberger E, Volchkov V, Paragas J, Klenk HD, Garcia-Sastre A, Palese P (2000) The Ebola virus VP35 protein functions as a type I IFN antagonist. Proc Natl Acad Sci USA 97:12289–12294PubMedCrossRef
3.
go back to reference Brunotte L, Kerber R, Shang W, Hauer F, Hass M, Gabriel M, Lelke M, Busch C, Stark H, Svergun DI, Betzel C, Perbandt M, Günther S (2011) Structure of the Lassa virus nucleoprotein revealed by X-ray crystallography, small-angle X-ray scattering, and electron microscopy. J Biol Chem 286:38748–38756PubMedCrossRef Brunotte L, Kerber R, Shang W, Hauer F, Hass M, Gabriel M, Lelke M, Busch C, Stark H, Svergun DI, Betzel C, Perbandt M, Günther S (2011) Structure of the Lassa virus nucleoprotein revealed by X-ray crystallography, small-angle X-ray scattering, and electron microscopy. J Biol Chem 286:38748–38756PubMedCrossRef
4.
go back to reference Buchholz UJ, Finke S, Conzelmann KK (1999) Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter. J Virol 73:251–259PubMed Buchholz UJ, Finke S, Conzelmann KK (1999) Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter. J Virol 73:251–259PubMed
5.
go back to reference Buchmeier MJ, De La Torre JC, Peters CJ (2007) Arenaviridae: the viruses and their replication. In: Knipe DM, Howley PM (eds) Fields virology. Lippincott Williams & Wilkins, pp 1791–1828 Buchmeier MJ, De La Torre JC, Peters CJ (2007) Arenaviridae: the viruses and their replication. In: Knipe DM, Howley PM (eds) Fields virology. Lippincott Williams & Wilkins, pp 1791–1828
6.
go back to reference Casabona JC, Levingston Macleod JM, Loureiro ME, Gomez GA, Lopez N (2009) The RING domain and the L79 residue of Z protein are involved in both the rescue of nucleocapsids and the incorporation of glycoproteins into infectious chimeric arenavirus-like particles. J Virol 83:7029–7039PubMedCrossRef Casabona JC, Levingston Macleod JM, Loureiro ME, Gomez GA, Lopez N (2009) The RING domain and the L79 residue of Z protein are involved in both the rescue of nucleocapsids and the incorporation of glycoproteins into infectious chimeric arenavirus-like particles. J Virol 83:7029–7039PubMedCrossRef
7.
go back to reference Clegg J (1992) Current progress towards vaccines for arenavirus-caused diseases. Vaccine 10:89–184PubMedCrossRef Clegg J (1992) Current progress towards vaccines for arenavirus-caused diseases. Vaccine 10:89–184PubMedCrossRef
8.
go back to reference DiCarlo A, Möller P, Lander A, Kolesnikova L, Becker S (2007) Nucleocapsid formation and RNA synthesis of Marburg virus is dependent on two coiled coil motifs in the nucleoprotein. Virol J 4:105PubMedCrossRef DiCarlo A, Möller P, Lander A, Kolesnikova L, Becker S (2007) Nucleocapsid formation and RNA synthesis of Marburg virus is dependent on two coiled coil motifs in the nucleoprotein. Virol J 4:105PubMedCrossRef
9.
go back to reference Eichler R, Strecker T, Kolesnikova L, ter Meulen J, Weissenhorn W, Becker S, Klenk HD, Garten W, Lenz O (2004) Characterization of the Lassa virus matrix protein Z: electron microscopic study of virus-like particles and interaction with the nucleoprotein (NP). Virus Res 100:249–255PubMedCrossRef Eichler R, Strecker T, Kolesnikova L, ter Meulen J, Weissenhorn W, Becker S, Klenk HD, Garten W, Lenz O (2004) Characterization of the Lassa virus matrix protein Z: electron microscopic study of virus-like particles and interaction with the nucleoprotein (NP). Virus Res 100:249–255PubMedCrossRef
10.
go back to reference Geisbert TW, Jones S, Fritz EA, Shurtleff AC, Geisbert JB, Liebscher R, Grolla A, Ströher U, Fernando L, Daddario KM, Guttieri MC, Mothe BR, Larsen T, Hensley LE, Jahrling PB, Feldmann H (2005) Development of a new vaccine for the prevention of Lassa fever. PLoS Med 2:e183PubMedCrossRef Geisbert TW, Jones S, Fritz EA, Shurtleff AC, Geisbert JB, Liebscher R, Grolla A, Ströher U, Fernando L, Daddario KM, Guttieri MC, Mothe BR, Larsen T, Hensley LE, Jahrling PB, Feldmann H (2005) Development of a new vaccine for the prevention of Lassa fever. PLoS Med 2:e183PubMedCrossRef
11.
go back to reference Groseth A, Wolff S, Strecker T, Hoenen T, Becker S (2010) Efficient budding of the tacaribe virus matrix protein z requires the nucleoprotein. J Virol 84:3603–3611PubMedCrossRef Groseth A, Wolff S, Strecker T, Hoenen T, Becker S (2010) Efficient budding of the tacaribe virus matrix protein z requires the nucleoprotein. J Virol 84:3603–3611PubMedCrossRef
12.
go back to reference Günther S, Lenz O (2004) Lassa virus. Critical reviews in clinical laboratory sciences 41:339–429PubMedCrossRef Günther S, Lenz O (2004) Lassa virus. Critical reviews in clinical laboratory sciences 41:339–429PubMedCrossRef
13.
go back to reference Hass M, Golnitz U, Müller S, Becker-Ziaja B, Günther S (2004) Replicon system for Lassa virus. J Virol 78:13793–13803PubMedCrossRef Hass M, Golnitz U, Müller S, Becker-Ziaja B, Günther S (2004) Replicon system for Lassa virus. J Virol 78:13793–13803PubMedCrossRef
14.
go back to reference Hastie K, Kimberlin C, Zandonatti M, MacRae I, Saphire E (2011) Structure of the Lassa virus nucleoprotein reveals a dsRNA-specific 3’ to 5’ exonuclease activity essential for immune suppression. Proc Natl Acad Sci USA 108:2396–2797PubMedCrossRef Hastie K, Kimberlin C, Zandonatti M, MacRae I, Saphire E (2011) Structure of the Lassa virus nucleoprotein reveals a dsRNA-specific 3’ to 5’ exonuclease activity essential for immune suppression. Proc Natl Acad Sci USA 108:2396–2797PubMedCrossRef
15.
go back to reference Hastie KM, Liu T, Li S, King LB, Ngo N, Zandonatti MA, Woods VL Jr, de la Torre JC, Saphire EO (2011) Crystal structure of the Lassa virus nucleoprotein-RNA complex reveals a gating mechanism for RNA binding. Proc Natl Acad Sci USA 108:19365–19370PubMedCrossRef Hastie KM, Liu T, Li S, King LB, Ngo N, Zandonatti MA, Woods VL Jr, de la Torre JC, Saphire EO (2011) Crystal structure of the Lassa virus nucleoprotein-RNA complex reveals a gating mechanism for RNA binding. Proc Natl Acad Sci USA 108:19365–19370PubMedCrossRef
16.
go back to reference Jacamo R, Lopez N, Wilda M, Franze-Fernandez MT (2003) Tacaribe virus Z protein interacts with the L polymerase protein to inhibit viral RNA synthesis. J Virol 77:10383–10393PubMedCrossRef Jacamo R, Lopez N, Wilda M, Franze-Fernandez MT (2003) Tacaribe virus Z protein interacts with the L polymerase protein to inhibit viral RNA synthesis. J Virol 77:10383–10393PubMedCrossRef
17.
go back to reference Jiang X, Dalebout TJ, Bredenbeek PJ, Carrion R Jr, Brasky K, Patterson J, Goicochea M, Bryant J, Salvato MS, Lukashevich IS (2011) Yellow fever 17D-vectored vaccines expressing Lassa virus GP1 and GP2 glycoproteins provide protection against fatal disease in guinea pigs. Vaccine 29:1248–1257PubMedCrossRef Jiang X, Dalebout TJ, Bredenbeek PJ, Carrion R Jr, Brasky K, Patterson J, Goicochea M, Bryant J, Salvato MS, Lukashevich IS (2011) Yellow fever 17D-vectored vaccines expressing Lassa virus GP1 and GP2 glycoproteins provide protection against fatal disease in guinea pigs. Vaccine 29:1248–1257PubMedCrossRef
18.
go back to reference Kerber R, Rieger T, Busch C, Flatz L, Pinschewer DD, Kummerer BM, Günther S (2011) Cross-species analysis of the replication complex of old world arenaviruses reveals two nucleoprotein sites involved in L protein function. J Virol 85:12518–12528PubMedCrossRef Kerber R, Rieger T, Busch C, Flatz L, Pinschewer DD, Kummerer BM, Günther S (2011) Cross-species analysis of the replication complex of old world arenaviruses reveals two nucleoprotein sites involved in L protein function. J Virol 85:12518–12528PubMedCrossRef
19.
go back to reference Kimberlin CR, Bornholdt ZA, Li S, Woods VL Jr, MacRae IJ, Saphire EO (2010) Ebolavirus VP35 uses a bimodal strategy to bind dsRNA for innate immune suppression. Proc Natl Acad Sci USA 107:314–319PubMedCrossRef Kimberlin CR, Bornholdt ZA, Li S, Woods VL Jr, MacRae IJ, Saphire EO (2010) Ebolavirus VP35 uses a bimodal strategy to bind dsRNA for innate immune suppression. Proc Natl Acad Sci USA 107:314–319PubMedCrossRef
20.
go back to reference Lee KJ, Novella IS, Teng MN, Oldstone MB, de La Torre JC (2000) NP and L proteins of lymphocytic choriomeningitis virus (LCMV) are sufficient for efficient transcription and replication of LCMV genomic RNA analogs. J Virol 74:3470–3477PubMedCrossRef Lee KJ, Novella IS, Teng MN, Oldstone MB, de La Torre JC (2000) NP and L proteins of lymphocytic choriomeningitis virus (LCMV) are sufficient for efficient transcription and replication of LCMV genomic RNA analogs. J Virol 74:3470–3477PubMedCrossRef
21.
go back to reference Levingston Macleod JM, D’Antuono A, Loureiro ME, Casabona JC, Gomez GA, Lopez N (2011) Identification of two functional domains within the arenavirus nucleoprotein. J Virol 85:2012–2023PubMedCrossRef Levingston Macleod JM, D’Antuono A, Loureiro ME, Casabona JC, Gomez GA, Lopez N (2011) Identification of two functional domains within the arenavirus nucleoprotein. J Virol 85:2012–2023PubMedCrossRef
22.
go back to reference Lopez N, Jacamo R, Franze-Fernandez MT (2001) Transcription and RNA replication of tacaribe virus genome and antigenome analogs require N and L proteins: Z protein is an inhibitor of these processes. J Virol 75:12241–12251PubMedCrossRef Lopez N, Jacamo R, Franze-Fernandez MT (2001) Transcription and RNA replication of tacaribe virus genome and antigenome analogs require N and L proteins: Z protein is an inhibitor of these processes. J Virol 75:12241–12251PubMedCrossRef
23.
go back to reference Martinez-Sobrido L, Giannakas P, Cubitt B, Garcia-Sastre A, de la Torre JC (2007) Differential inhibition of type I interferon induction by arenavirus nucleoproteins. J Virol 81:12696–12703PubMedCrossRef Martinez-Sobrido L, Giannakas P, Cubitt B, Garcia-Sastre A, de la Torre JC (2007) Differential inhibition of type I interferon induction by arenavirus nucleoproteins. J Virol 81:12696–12703PubMedCrossRef
24.
go back to reference Ortiz-Riano E, Cheng BY, de la Torre JC, Martinez-Sobrido L (2011) The C-terminal region of lymphocytic choriomeningitis virus nucleoprotein contains distinct and segregable functional domains involved in NP-Z interaction and counteraction of the type I interferon response. J Virol 85:13038–13048PubMedCrossRef Ortiz-Riano E, Cheng BY, de la Torre JC, Martinez-Sobrido L (2011) The C-terminal region of lymphocytic choriomeningitis virus nucleoprotein contains distinct and segregable functional domains involved in NP-Z interaction and counteraction of the type I interferon response. J Virol 85:13038–13048PubMedCrossRef
25.
go back to reference Ortiz-Riano E, Cheng BY, de la Torre JC, Martinez-Sobrido L (2012) Self-association of lymphocytic choriomeningitis virus nucleoprotein is mediated by its N-terminal region and is not required for its anti-interferon function. J Virol 86:3307–3317PubMedCrossRef Ortiz-Riano E, Cheng BY, de la Torre JC, Martinez-Sobrido L (2012) Self-association of lymphocytic choriomeningitis virus nucleoprotein is mediated by its N-terminal region and is not required for its anti-interferon function. J Virol 86:3307–3317PubMedCrossRef
26.
go back to reference Ortiz-Riano E, Cheng BY, de la Torre JC, Martinez-Sobrido L (2012) D471G mutation in LCMV-NP affects its ability to self-associate and results in a dominant negative effect in viral RNA synthesis. Viruses 4:2137–2161PubMedCrossRef Ortiz-Riano E, Cheng BY, de la Torre JC, Martinez-Sobrido L (2012) D471G mutation in LCMV-NP affects its ability to self-associate and results in a dominant negative effect in viral RNA synthesis. Viruses 4:2137–2161PubMedCrossRef
27.
go back to reference Pinschewer D, Perez M, de la Torre J (2003) Role of the virus nucleoprotein in the regulation of lymphocytic choriomeningitis virus transcription and RNA replication. J Virol 77:3882–3889PubMedCrossRef Pinschewer D, Perez M, de la Torre J (2003) Role of the virus nucleoprotein in the regulation of lymphocytic choriomeningitis virus transcription and RNA replication. J Virol 77:3882–3889PubMedCrossRef
28.
go back to reference Qi X, Lan S, Wang W, Schelde L, Dong H, Wallat G, Ly H, Liang Y, Dong C (2010) Cap binding and immune evasion revealed by Lassa nucleoprotein structure. Nature 468:779–862PubMedCrossRef Qi X, Lan S, Wang W, Schelde L, Dong H, Wallat G, Ly H, Liang Y, Dong C (2010) Cap binding and immune evasion revealed by Lassa nucleoprotein structure. Nature 468:779–862PubMedCrossRef
29.
go back to reference Reid SP, Cardenas WB, Basler CF (2005) Homo-oligomerization facilitates the interferon-antagonist activity of the ebolavirus VP35 protein. Virology 341:179–189PubMedCrossRef Reid SP, Cardenas WB, Basler CF (2005) Homo-oligomerization facilitates the interferon-antagonist activity of the ebolavirus VP35 protein. Virology 341:179–189PubMedCrossRef
30.
go back to reference Ruigrok RW, Crepin T, Kolakofsky D (2011) Nucleoproteins and nucleocapsids of negative-strand RNA viruses. Curr Opin Microbiol 14:504–510PubMedCrossRef Ruigrok RW, Crepin T, Kolakofsky D (2011) Nucleoproteins and nucleocapsids of negative-strand RNA viruses. Curr Opin Microbiol 14:504–510PubMedCrossRef
31.
go back to reference Schlie K, Maisa A, Freiberg F, Groseth A, Strecker T, Garten W (2010) Viral protein determinants of Lassa virus entry and release from polarized epithelial cells. J Virol 84:3178–3188PubMedCrossRef Schlie K, Maisa A, Freiberg F, Groseth A, Strecker T, Garten W (2010) Viral protein determinants of Lassa virus entry and release from polarized epithelial cells. J Virol 84:3178–3188PubMedCrossRef
32.
go back to reference Schlie K, Maisa A, Lennartz F, Ströher U, Garten W, Strecker T (2010) Characterization of Lassa virus glycoprotein oligomerization and influence of cholesterol on virus replication. J Virol 84:983–992PubMedCrossRef Schlie K, Maisa A, Lennartz F, Ströher U, Garten W, Strecker T (2010) Characterization of Lassa virus glycoprotein oligomerization and influence of cholesterol on virus replication. J Virol 84:983–992PubMedCrossRef
33.
go back to reference Shtanko O, Imai M, Goto H, Lukashevich IS, Neumann G, Watanabe T, Kawaoka Y (2010) A role for the C terminus of Mopeia virus nucleoprotein in its incorporation into Z protein-induced virus-like particles. J Virol 84:5415–5422PubMedCrossRef Shtanko O, Imai M, Goto H, Lukashevich IS, Neumann G, Watanabe T, Kawaoka Y (2010) A role for the C terminus of Mopeia virus nucleoprotein in its incorporation into Z protein-induced virus-like particles. J Virol 84:5415–5422PubMedCrossRef
34.
go back to reference Strecker T, Eichler R, Meulen J, Weissenhorn W, Klenk HD, Garten W, Lenz O (2003) Lassa virus Z protein is a matrix protein and sufficient for the release of virus-like particles [corrected]. J Virol 77:10700–10705PubMedCrossRef Strecker T, Eichler R, Meulen J, Weissenhorn W, Klenk HD, Garten W, Lenz O (2003) Lassa virus Z protein is a matrix protein and sufficient for the release of virus-like particles [corrected]. J Virol 77:10700–10705PubMedCrossRef
35.
go back to reference Sutter G, Ohlmann M, Erfle V (1995) Non-replicating vaccinia vector efficiently expresses bacteriophage T7 RNA polymerase. FEBS Lett 371:9–12PubMedCrossRef Sutter G, Ohlmann M, Erfle V (1995) Non-replicating vaccinia vector efficiently expresses bacteriophage T7 RNA polymerase. FEBS Lett 371:9–12PubMedCrossRef
36.
go back to reference Ye Q, Krug RM, Tao YJ (2006) The mechanism by which influenza A virus nucleoprotein forms oligomers and binds RNA. Nature 444:1078–1082PubMedCrossRef Ye Q, Krug RM, Tao YJ (2006) The mechanism by which influenza A virus nucleoprotein forms oligomers and binds RNA. Nature 444:1078–1082PubMedCrossRef
Metadata
Title
The role of oligomerization for the biological functions of the arenavirus nucleoprotein
Authors
Frank Lennartz
Thomas Hoenen
Maria Lehmann
Allison Groseth
Wolfgang Garten
Publication date
01-09-2013
Publisher
Springer Vienna
Published in
Archives of Virology / Issue 9/2013
Print ISSN: 0304-8608
Electronic ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-013-1684-9

Other articles of this Issue 9/2013

Archives of Virology 9/2013 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.